enzalutamide 40 MG Oral Tablet
- RxCUI
- 2390644
- RxNorm name
- enzalutamide 40 MG Oral Tablet
- Display name
- enzalutamide 40 MG Oral Tablet
- Full name
- enzalutamide 40 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xtandi | ENZALUTAMIDE | Astellas Pharma US, Inc. | b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf | 2026-05-26 | Warnings, Adverse reactions | 2390644 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf | enzalutamide 40 MG Oral Tablet | PSN | 22 | These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI ® (enzalutamide) capsules, for oral use XTANDI ® (enzalutamide) tablets, for oral use Initial U.S. Approval: 2012 | 20251212 |
| b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf | enzalutamide 40 MG Oral Tablet | SCD | 22 | These highlights do not include all the information needed to use XTANDI safely and effectively. See full prescribing information for XTANDI. XTANDI ® (enzalutamide) capsules, for oral use XTANDI ® (enzalutamide) tablets, for oral use Initial U.S. Approval: 2012 | 20251212 |